Contract Grant Sponsors: University of Bergen; Research Council of Norway; Western Regional Health Authorities; K. G. Jebsen Foundation.
Functional Studies of Tyrosine Hydroxylase Missense Variants Reveal Distinct Patterns of Molecular Defects in Dopa-Responsive Dystonia
Version of Record online: 3 JUN 2014
© 2014 The Authors. *Human Mutation published by Wiley Periodicals, Inc.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Volume 35, Issue 7, pages 880–890, July 2014
How to Cite
Fossbakk, A., Kleppe, R., Knappskog, P. M., Martinez, A. and Haavik, J. (2014), Functional Studies of Tyrosine Hydroxylase Missense Variants Reveal Distinct Patterns of Molecular Defects in Dopa-Responsive Dystonia. Hum. Mutat., 35: 880–890. doi: 10.1002/humu.22565
Communicated by Mireille Claustres
- Issue online: 10 JUN 2014
- Version of Record online: 3 JUN 2014
- Accepted manuscript online: 21 APR 2014 08:10PM EST
- Manuscript Accepted: 10 APR 2014
- Manuscript Received: 1 JAN 2014
- University of Bergen; Research Council of Norway
- Western Regional Health Authorities
- K. G. Jebsen Foundation
- 2002. Crystal structure of the ternary complex of the catalytic domain of human phenylalanine hydroxylase with tetrahydrobiopterin and 3-(2-thienyl)-l-alanine, and its implications for the mechanism of catalysis and substrate activation. J Mol Biol 320:1095–1108. , , .
- 2010. A rare novel deletion of the tyrosine hydroxylase gene in Parkinson disease. Hum Mutat 31:E1767–E771. , , , , , , , .
- 2011. Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies. Mol Genet Metab 104(Suppl):S2–S9. , , , .
- 1999. Biochemical and molecular genetic characteristics of the severe form of tyrosine hydroxylase deficiency. Clin Chem 45:2073–2078. , , , , , , .
- 2013. GTP cyclohydrolase I and tyrosine hydroxylase gene mutations in familial and sporadic dopa-responsive dystonia patients. PLoS One 8:e65215. , , , , , , , , .
- 2010. Effect of pharmacological chaperones on brain tyrosine hydroxylase and tryptophan hydroxylase 2. J Neurochem 114:853–863. , , , , , , , , .
- 2008. Rhesus monkey tryptophan hydroxylase-2 coding region haplotypes affect mRNA stability. Neuroscience 155:485–491. , .
- 2012. Tyrosine hydroxylase deficiency in Taiwanese infants. Pediatr Neurol 46:77–82. , , .
- 2009. Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia. Brain 132(Pt 7):1753–1763. , , , , , , , , , , , , et al.
- 2013. Mutagenesis of a specificity-determining residue in tyrosine hydroxylase establishes that the enzyme is a robust phenylalanine hydroxylase but a fragile tyrosine hydroxylase. Biochemistry 52:1446–1455. , , , , , , , , , , , .
- 1995. Deletion mutants of tyrosine hydroxylase identify a region critical for heparin binding. Protein Sci 4:538–541. , .
- 2009. Infantile hypokinetic-hypotonic syndrome due to two novel mutations of the tyrosine hydroxylase gene. Mov Disord 24:943–945. , , , , , , , , , .
- 1999. Tetrahydropterin-dependent amino acid hydroxylases. Annu Rev Biochem 68:355–381.
- 1999. Tyrosine hydroxylase binds tetrahydrobiopterin cofactor with negative cooperativity, as shown by kinetic analyses and surface plasmon resonance detection. Eur J Biochem 262:840–849. , , , , , , , .
- 2013. Phenylalanine hydroxylase: function, structure, and regulation. IUBMB Life 65:341–349. , .
- 2005. An oxygraphic method for determining kinetic properties and catalytic mechanism of aromatic amino acid hydroxylases. Anal Biochem 343:100–105. , .
- 2008. Loss of function in phenylketonuria is caused by impaired molecular motions and conformational instability. Am J Hum Genet 83:5–17. , , , , , , , , .
- 2012. A new tyrosine hydroxylase genotype associated with early-onset severe encephalopathy. J Child Neurol 27:523–525. , , , , , , , .
- 1995. Control of mitochondrial and cellular respiration by oxygen. J Bioenerg Biomembr 27:583–596. , , , , .
- 1997. Crystal structure of tyrosine hydroxylase at 2.3 A and its implications for inherited neurodegenerative diseases. Nat Struct Biol 4:578–585. , , , , , .
- 2009. Differential regulation of human tyrosine hydroxylase isoforms 1 and 2 in situ: isoform 2 is not phosphorylated at Ser35. Biochim Biophys Acta 1793:1860–1867. , , , .
- 1987. A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics. Nature 326:707–711. , , , , , .
- 1997. l-DOPA is a substrate for tyrosine hydroxylase. J Neurochem 69:1720–1728.
- 1997. Generation of reactive oxygen species by tyrosine hydroxylase: a possible contribution to the degeneration of dopaminergic neurons? J Neurochem 68:328–332. , , .
- 1980. Rapid and sensitive assay of tyrosine 3-monooxygenase activity by high-performance liquid chromatography using the native fluorescence of DOPA. J Chromatogr 198:511–515. , .
- 1991. Recombinant human tyrosine hydroxylase isozymes. Reconstitution with iron and inhibitory effect of other metal ions. Eur J Biochem 199:371–378. , , , , .
- 1998. Tyrosine hydroxylase and Parkinson's disease. Mol Neurobiol 16:285–309. , .
- 2011. A novel compound heterozygous tyrosine hydroxylase mutation (p.R441P) with complex phenotype. J Parkinsons Dis 1:119–122. , .
- 2003. Spectroscopic and kinetic studies of PKU-inducing mutants of phenylalanine hydroxylase: Arg158Gln and Glu280Lys. J Am Chem Soc 125:5677–5686. , , , , , , , , .
- 2004. Different stabilities and denaturation pathways for structurally related aromatic amino acid hydroxylases. FEBS Lett 565(1–3):155–159. , .
- 1999. Urea-induced denaturation of human phenylalanine hydroxylase. J Biol Chem 274:33251–33258. , , , .
- 1995. Recessively inherited l-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum Mol Genet 4:1209–1212. , , , , .
- 2002. Neuroprotective and neurotoxic roles of levodopa (l-DOPA) in neurodegenerative disorders relating to Parkinson's disease. Amino Acids 23(1–3):57–63. , , .
- 2009. Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics 25:2744–2750. , , , , , , , .
- 1995. Frequent sequence variant in the human tyrosine hydroxylase gene. Hum Genet 95:716. , .
- 1996. Recessively inherited l-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Hum Mol Genet 5:1023–1028. , , , , , , , , .
- 2010. Biochemical and molecular characterization of tyrosine hydroxylase deficiency in Hong Kong Chinese. Mol Genet Metab 99:431–433. , , , , , , , , , , , , et al.
- 2004. Expression and purification of human tryptophan hydroxylase from Escherichia coli and Pichia pastoris. Protein Expr Purif 33:185–194. , , , , , , , , , .
- 2009. Functional properties of missense variants of human tryptophan hydroxylase 2. Hum Mutat 30:787–794. , , , , .
- 2010. Phenylketonuria as a model for protein misfolding diseases and for the development of next generation orphan drugs for patients with inborn errors of metabolism. J Inherit Metab Dis 33:649–658. , .
- 1991. Comparative studies on the structure of human tyrosine hydroxylase with those of the enzyme of various mammals. Comp Biochem Physiol C 98:203–210. , .
- 2013. A possible pathophysiological role of tyrosine hydroxylase in Parkinson's disease suggested by postmortem brain biochemistry: a contribution for the special 70th birthday symposium in honor of Prof. Peter Riederer. J Neural Transm 120:49–54. , , , , , .
- 1994. Recombinant human tyrosine hydroxylase types 1–4 show regulatory kinetic properties for the natural (6R)-tetrahydrobiopterin cofactor. J Biochem 116:393–398. , , , .
- 2004. Mechanisms underlying responsiveness to tetrahydrobiopterin in mild phenylketonuria mutations. Hum Mutat 24:388–399. , , , , , , , , , , .
- 2007. Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases. Am J Hum Genet 81:1006–1024. , , , .
- 2013. Levodopa-induced dyskinesias in tyrosine hydroxylase deficiency. Mov Disord 28:1058–1063. , , , , , , , , , .
- 2008. Oxygen dependence of tyrosine hydroxylase. Amino Acids 34:455–464. , , , , , .
- 2005. Effects of mutations in tyrosine hydroxylase associated with progressive dystonia on the activity and stability of the protein. Proteins 58:14–21. , , .
- 2005. The FoldX web server: an online force field. Nucleic Acids Res 33(Web Server issue):W382–W388. , , , , , .
- 2007. The PAH gene, phenylketonuria, and a paradigm shift. Hum Mutat 28:831–845. .
- 2012. Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency. Neurology 79:435–441. , , , , , , , .
- 2004. Tetrahydrobiopterin binding to aromatic amino acid hydroxylases. Ligand recognition and specificity. J Med Chem 47:5962–5971. , , , , , , , .
- 2008. Tetrahydrobiopterin shows chaperone activity for tyrosine hydroxylase. J Neurochem 106:672–681. , , , , , , .
- 2010. Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis. Brain 133(Pt 6):1810–1822. , , , , , , , , , , , , et al.
- 1995. Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 374:640–643. , , .